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Abstract
Ligand-dependent activation of the Hedgehog (Hh) signaling pathway has been implicated in both tumor initiation
and metastasis of pancreatic ductal adenocarcinoma (PDAC). Prior studies in genetically engineered mouse models
(GEMMs) have assessed the role of Hh signaling by cell autonomous expression of a constitutively active Gli2 within
epithelial cells. On the contrary, aberrant pathway reactivation in the human exocrine pancreas occurs principally
as a consequence of Sonic Hh ligand (Shh) overexpression from epithelial cells. To recapitulate the cognate patho-
physiology of Hh signaling observed in the human pancreas, we examined GEMM where Hh ligand is condition-
ally overexpressed within the mature exocrine pancreas using a tamoxifen-inducible Elastase-Cre promoter
(Ela-CreERT2;LSL-mShh). We also facilitated potential cell autonomous epithelial responsiveness to secreted Hh li-
gand by generating compound transgenic mice with concomitant expression of the Hh receptor Smoothened (Ela-
CreERT2;LSL-mShh;LSL-mSmo). Of interest, none of these mice developed intraductal precursor lesions or PDAC
during the follow-up period of up to 12 months after tamoxifen induction. Instead, all animals demonstrated marked
expansion of stromal cells, consistent with the previously described epithelial-to-stromal paracrine Hh signaling. Hh
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responsiveness was mirrored by the expression of primary cilia within the expanded mesenchymal compartment
and the absence within mature acinar cells. In the absence of cooperating mutations, Hh ligand overexpression
in the mature exocrine pancreas is insufficient to induce neoplasia, even when epithelial cells coexpress the
Smo receptor. This autochthonous model serves as a platform for studying epithelial stromal interactions in pan-
creatic carcinogenesis.
Neoplasia (2011) 13, 923–930
Introduction
Ductal adenocarcinoma of the pancreas (a.k.a. pancreatic cancer) is
one of the most deadly of human malignancies to date and is asso-
ciated with almost uniform lethality [1]. Accounting for an estimated
36,400 fatalities in the United States alone in 2010, pancreatic can-
cer represents the fourth most common cause of cancer-related mor-
tality in the western world [2]. Moreover, approximately 80% of
cases are diagnosed at locally advanced or metastatic tumor stages,
usually precluding surgical resection and leaving patients without
any curative therapeutic option. With an overall survival of less than
6 months and 5-year survival rates below 5%, the dismal overall
prognosis of pancreatic cancer has not markedly improved during
the past decades [1,3,4].
Multiple lines of evidence implicate the Hedgehog (Hh) signaling
pathway playing a role in both pancreatic cancer initiation and pro-
gression [5,6], as well as representing a promising target for therapeu-
tic intervention [7–13]. The basis for aberrant pathway activation in
pancreatic cancer is usually not a consequence of oncogenic muta-
tions within canonical Hh pathway components but rather secondary
to endogenous overexpression of Hedgehog ligands by neoplastic
epithelial cells [5,7,8,14]. Conversely, the nature of the Hh-receiving
cells in the context of pancreatic cancer is less clearly defined. Various
models have been proposed, including stimulation of “bulk” neo-
plastic epithelial cells in an autocrine or paracrine manner, mainte-
nance of a putative subpopulation of neoplastic epithelial cells with
enhanced tumorigenic potential (also referred to as “cancer stem cells”
by some authors), and most recently, proliferative effects on stromal
cells of mesenchymal origin within the tumor microenvironment, as
well as combinations of these models [15,16].
Among the more powerful tools in understanding the mechanisms
underlying pancreatic carcinogenesis has been the development of ge-
netically engineered mouse models of pancreatic cancer [17–19]. In
this present study, we describe a genetically engineered mouse model
in which Sonic Hedgehog ligand (Shh) is overexpressed in the acinar
cell compartment of adult murine pancreata. In contrast to prior re-
ports that relied on the ectopic expression of a constitutively activated
Gli2 in the murine pancreas [20], we recapitulated “physiological”
conditions by inducing endogenous Hedgehog ligand expression from
the adult exocrine cells. In this model, we fail to observe evidence of
intraductal neoplasia in the absence of cooperating mutations, such as
oncogenic Kras. Instead, the Shh ligand–overexpressing murine pan-
creata demonstrate a striking expansion of the periacinar mesenchymal
compartment, consistent with paracrine epithelial-stromal signaling.
This model should serve as a platform for elucidating epithelial-stromal
interactions in the context of exocrine pancreatic neoplasia and, fur-
ther, for developing relevant examples of oncogenic cooperation with
Hh signaling.
Materials and Methods
Generation of Pdx1-Cre;LSL-mShh, Elastase-CreERT2;LSL-mShh,
and Elastase-CreERT2;LSL-mShh;LSL-mSmo Mouse Cohorts
Generation of LSL-mShh mice has been described previously [21].
In brief, in this model, Cre-mediated recombination leads to excision
of the lox-stop-lox (LSL) cassette and conditional expression of mShh
ligand (Figure 1A). An identical strategy is used for driving expression
of Smo receptor protein in the recombined cells of compound trans-
genic LSL-mShh, LSL-mSmo mice. Mice interbred and reproduced
readily with an even distribution of female-to-male ratio of approxi-
mately 1:1. The presence of a constitutive fluorescent protein expres-
sion in nonrecombined tissues (e.g., tail snips) enables rapid detection
of the LSL-mShh or LSL-mSmo allele, by green or red fluorescence,
respectively. The “driver” Pdx1-Cre and Elastase (Ela)-CreERT2 mice
have been previously described [22,23]. The presence of Cre or
CreERT2 alleles, respectively, was determined by polymerase chain
reaction analysis, as previously described [23,24].
Two different reporter mouse crosses were generated in our studies:
the first, to confirm the robustness of Cre-mediated recombination in
the pancreatic acinar compartment, we generated Ela-CreERT2;
Rosa26R mice, which harbor a beta-galactosidase gene downstream of
a ubiquitous promoter and a LSL cassette. Second, to demonstrate
Hh pathway activity within specific pancreatic compartments, the
Ela-CreERT2;LSL-mShh mice were also crossed into a Ptch-lacZ back-
ground; in this latter strain, the lacZ allele is knocked into one of the
Ptch loci, and the resulting beta-galactosidase activity (indicative of Hh
pathway activity) can be visualized by X-Gal staining [24,25].
The following three cohorts of mice with pancreas-specific Shh
ligand overexpression were generated for observation: Pdx1-cre;
LSL-mShh, Ela-CreERT2;LSL-mShh, and Ela-CreERT2;LSL-
mShh;mSmo. For the mice bearing tamoxifen-inducible ERT2 alleles,
induction was carried out at the age of 6 weeks after birth by intra-
peritoneal injection of tamoxifen on five consecutive days as described
previously [24]. Saline-injected mice of the same genotype were used
as controls. Cohorts of at least five tamoxifen-induced, as well as at
least two uninduced mice of each genotype were then killed at two
monthly intervals, for the period ranging from 2 to 12 months after
tamoxifen injection. At the end of the follow-up period, mice were
killed by CO2 insufflation, and the pancreata were harvested and fixed
in 10% neutral buffered formalin solution for paraffin embedding. In
924 Pancreas-Specific Overexpression of Shh in GEM Fendrich et al. Neoplasia Vol. 13, No. 10, 2011
some cases, parts of the pancreata were immediately snap frozen in
liquid nitrogen and then stored at −80°C until further use.
Immunohistochemistry
Immunolabeling of Shh and X-Gal staining were performed as
previously described [24,26].
Immunofluorescence and Confocal Microscopy
Paraffin sections from Ela-CreERT2;LSL-mShh murine pancreata
were collected and treated with antigen retrieval solution (Dako,
Hamburg, Germany). The sections were probed overnight with the
following antibodies: rabbit anti-insulin (Santa Cruz Biotechnology,
Santa Cruz, CA), rabbit anti–Pan-cytokeratin (Abcam, Cambridge,
United Kingdom), rabbit anti-amylase (Abcam), and mouse anti–
acetylated-tubulin (Sigma, St Louis, MO). After washes in 0.1%
PBS–Triton X-100, fluorescent detection was performed using Alexa
Fluor 488 and 546 (Invitrogen, Carlsbad, CA)–conjugated secondary
antibodies. Images were acquired using a Zeiss LSM510 confocal micro-
scope and digitized using Zeiss Image Browser (Zeiss, Jena, Germany).
Results
Developmental Overexpression of Shh Ligand in the Pancreatic
Anlage Results in Malformation and Perinatal Lethality
In line with previous reports by others using comparable systems
(Pdx1-Shh transgenic mice) [6], developmental overexpression of Shh
led to pancreatic malformation and embryonic lethality in Pdx1-Cre;
LSL-mShh mice (Figure W1). The pancreata were characterized by
mucinous metaplastic glands and an expansion of intestinal-type
mesenchyme, analogous to what has been described with transgenic
ligand expression. These experiments confirmed the in vivo recombina-
torial efficacy of the LSL cassette and the ability to generate an ectopic
Shh ligand.
Aberrant Hh Ligand Expression in the Mature Pancreas Leads
to Mesenchymal Expansion without Intraductal Lesions
In light of the developmental anomalies observed with Pdx1-Cre;
LSL-mShh mice, we generated cohorts of Ela-CreERT2;LSL-mShh
mice capable of producing Hh ligands in the adult exocrine pancreas.
The Ela-CreERT2 allele is expressed within the mature acinar com-
partment on tamoxifen induction, as described [23]. To assess the
efficiency of Cre-mediated recombination within the adult exocrine
pancreas, we first generated tamoxifen-induced Ela-CreERT2;Rosa26R
reporter mice, which confirmed the robustness of the Elastase pro-
moter in conditional removal of the LSL cassette (Figure 1B); cerebellar
beta-galactosidase expression in heterozygous Ptch-lacZ mice was used
as positive control for the X-Gal staining (Figure 1C ). In contrast to
the Pdx1-Cre;LSL-mShh mice, embryonic malformations or sub-
sequent growth defects were not observed in the Ela-CreERT2;LSL-
mShh mice.
Cohorts of Ela-CreERT2;LSL-mShhmice were then observed for up
to 1 year after tamoxifen induction, with at least five induced and two
uninduced mice being killed at each interval of 2 months, beginning
at the second month after tamoxifen injection. As expected, the un-
induced mice did not demonstrate any microscopic abnormalities in
Figure 1. Targeting endogenous Shh expression to the adult murine pancreas. (A) The presence of the transgenic construct in somatic
cells can be verified by enhanced green fluorescent protein expression. Cre-mediated recombination of the LSL cassette leads to ex-
cision of the enhanced green fluorescent protein cassette and expression of Shh (described previously in Hingorani et al. [17]). (B) Posi-
tive X-Gal staining revealed robust Cre-mediated recombination in the exocrine pancreas of Ela-CreERT2;LSL-mShh;Rosa26R reporter
mice after induction with tamoxifen. (C) Uninduced mouse. (D) Cerebellum of heterozygous Ptch-lacZ mice served as a positive control
for X-Gal staining.
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the pancreas at any period during follow-up (Figure 2A). In contrast,
tamoxifen-induced mice demonstrated a progressive mesenchymal
expansion within the periacinar stroma, with the earliest histologic
evidence for the spindle-shaped cells seen as early as 2 months after
induction (Figure 2, B-D). Unlike the mutant Kras-driven mouse
models of pancreatic neoplasia, aberrant expression of Shh ligand alone
did not result in exocrine adenocarcinomas, intraductal precursor
lesions, or even widespread acinar-ductal metaplasia, including that
in mouse pancreata examined at 1 year after induction.
To address the possibility that the observed lack of Hh ligand
responsiveness of the epithelial compartment was due to absence of
the Smoothened (Smo) receptor, the entire study was repeated with
acinar cell coexpression of mSmo along with mShh by generating Ela-
CreERT2;LSL-mShh;LSL-mSmo compound transgenic mice. The ani-
mals were induced in the same manner as outlined above and observed
for up to 12 months after tamoxifen induction. Notably, the pancreatic
phenotype observed in the Ela-CreERT2;LSL-mShh;LSL-mSmo mice
was identical to that in the Ela-CreERT2;LSL-mShh mice, that is, no
intraductal lesions or neoplasms were identified, whereas a marked
expansion of periacinar stromal cell compartment was found, as already
described above (Figure 2, E-F). These results ruled out the possibility
that the observed lack of Hh responsiveness of acinar cells was simply
due to an overall lack of Smo expression as hypothesized originally.
Responsiveness to Ectopic Hh Ligand Is Restricted to the
Stromal Compartment
To further characterize the dynamics of Hh ligand–dependent sig-
naling in the exocrine pancreas, we assessed the localization of Shh,
Figure 2. Hh misexpression in the adult murine pancreas leads to mesenchymal expansion in the absence of intraductal lesions. (A) No
morphologic abnormalities were observed in the pancreata of Ela-CreERT2;LSL-mShh mice in the absence of tamoxifen induction.
(B-D) After tamoxifen induction, morphologic changes in the Ela-CreERT2;LSL-mShh pancreata were observed as early as 2 months
and persisted at 1 year of follow-up, at which time the study was terminated. The most conspicuous alteration was a marked expansion
of stromal cells between existing acinar lobules, displacing the acinar cells over time. Photomicrographs were obtained at 2 (B), 6 (C),
and 12 months (D) after tamoxifen induction, respectively. In contrast, no epithelial alterations such as intraductal precursor lesions or
exocrine cancers were found. (E and F) Comparable histologic alterations were observed in tamoxifen-induced Ela-CreERT2;LSL-mShh;
LSL-mSmo mice, beginning as early as 2 months after induction (E) and persisting up to 1 year (F). No intraductal precursor lesions or
exocrine cancers were seen in these cohorts either.
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Smo, and the Hh gene target Ptch in tamoxifen-induced mice. Over-
expression of Shh was observed in most acinar cells within the murine
pancreata by immunohistochemistry (Figure 3A), whereas immuno-
labeling of Smo was essentially confined to adjacent stromal cells
(Figure 3B). The localization of Ptch, assessed using Ela-CreERT2;
LSL-mShh;Ptch-lacZ reporter mice, mirrored that of Smo protein, con-
firming that the stromal compartment was the principal recipient of
the epithelial Hh ligand (Figure 3C). We were unable to demonstrate
any convincing acinar-specific beta-galactosidase expression in the
examined pancreata. In line with a mesenchymal nature of the Ptch-
expressing periacinar stromal compartment, immunofluorescence dem-
onstrated robust expression of nestin, a marker of mesenchymal cells in
the adult pancreas [27], whereas the epithelial antigen E-cadherin was
absent (Figure 3D).
Primary Cilia Are Absent on Cells within the
Acinar Compartment
Recent evidence suggests that the presence of primary cilia and re-
cruitment of the receptor protein Smo to the cilia are prerequisites for
the ability of a cell to respond to stimulation by Hh ligands, irrespec-
tive of the presence of other pathway components [28]. Therefore, the
presence of primary cilia was analyzed in pancreatic cryosections using
immunofluorescence for acetylated tubulin, a marker for primary cilia
[29]. Acetylated tubulin expression was observed within the ductal
epithelium, on pancreatic endocrine cells within islets of Langerhans,
and the expanded periacinar stromal compartment, but not in acinar
cells of Ela-CreERT2;LSL-mShh mice (Figure 4). The absence of pri-
mary cilia in acinar cells likely explains the lack of demonstrable cell
autonomous effects from the secreted Hh ligand, including in com-
pound transgenic Ela-CreERT2;LSL-mShh;LSL-mSmo mice.
Discussion
The identification of aberrant Hedgehog signaling in pancreatic can-
cer has led to significant research efforts aimed at exploiting this pathway
for the development of novel therapeutic options during the past few
years [5,6,30]. In fact, at present, there are several Hedgehog small-
molecule inhibitors available that are undergoing initial clinical eval-
uation and have shown promising in vivo efficacy in various human
cancers, including medulloblastoma and basal cell carcinoma [13,31–35].
However, despite this obviously encouraging progress in moving for-
ward the translational component, there is an incomplete understand-
ing of the mechanisms underlying the effects of aberrant Hh signaling
in pancreatic cancer. Specifically, there have been conflicting reports as
to the nature of cells within ductal adenocarcinomas that are competent
to receive, and respond to, secreted Hh ligands [15,16]. The initial
studies suggested that ligand expression and activation of the Hh path-
way occurred within the “bulk” population of neoplastic epithelial
cells in a cell autonomous manner [5,6]. Subsequent studies proposed
a somewhat restricted subpopulation of Hh-dependent neoplastic
cells within the epithelial compartment, specifically those with tumor-
initiating and metastatic dissemination capacity [7,9,11,36,37].
The most recent series of studies in pancreatic adenocarcinoma sug-
gest that the ability to respond to paracrine Hh ligand rests predomi-
nantly within stromal cells rather than the neoplastic cells themselves
Figure 3. Confirmation of stromal Hh pathway activity on Cre-mediated recombination in the exocrine pancreas. (A) Immunohisto-
chemistry confirmed the expression of Shh ligand in most acinar cells in tamoxifen-induced Ela-CreERT2;LSL-mShh mice. (B) In con-
trast, Smo expression was essentially restricted to the expanded periacinar stromal compartment in tamoxifen-induced Ela-CreERT2;
LSL-mShhmice. (C) The expanded stromal compartment had evidence of Hh activation, as confirmed by expression of beta-galactosidase
(blue) in tamoxifen-induced Ela-CreERT2;LSL-mShh;Ptch-lacZ reporter mice. This pattern overlapped with that of Smo receptor expression
in B. (D) The stromal population was negative for E-cadherin and expressed nestin, a feature of mesenchymal cells in the adult pancreas.
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[38,39]. Bailey et al. [40] demonstrated that peritumoral desmoplasia,
a feature most pronounced in pancreatic adenocarcinomas, is a con-
sequence of the paracrine activity of epithelial Hh ligand on stromal
cells. Furthermore, Olive et al. [10] showed that Hh inhibition using
a small-molecule inhibitor led to marked stromal depletion and en-
hanced drug delivery in an autochthonous mouse model of pancreatic
cancer. Similarly, Lauth et al. recently showed marked overexpression
of the Hh target gene Gli1 in tumor-associated stromal cells, but only
minimal expression in pancreatic adenocarcinoma, consistent with a
high pathway activity in the former but not the latter compartment
Figure 4. The expanded stromal compartment expresses markers of primary cilia. Acetylated tubulin expression was observed in (A) islets
marked by insulin and in (B) ducts marked by pan-cytokeratin (Pan CK) from Ela-CreERT2; LSL-mShh murine pancreata. In contrast, acety-
lated tubulin could not be detected by staining in amylase expressing acinar cells (C). (D) Stromal cells (white arrows) intermixed within
exocrine structures were identified using Nomarski optics. Expression of acetylated tubulin in these cells was consistent with the presence
of primary cilia within the stroma. Staining for insulin, pan CK, acetylated tubulin, and amylase as indicated. Scale bar, 10 μm.
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[41]. The dispensable nature of Hh signaling within the epithelial
compartment is reiterated by recent studies, which confirmed that
biallelic inactivation of Smo in pancreatic epithelial cells did not affect
subsequent development of adenocarcinoma in an autochthonous
model [42], whereas conversely, Smo inactivation in stromal cells led
to delayed growth of pancreatic cancer xenografts [38].
Prior reports examining the role of aberrant Hh signaling in the
epithelial compartment have largely relied on expression of a consti-
tutively active mGli2 allele that lacks the N-terminal repressor do-
main (GLI2ΔN) [20]. Thus, Pdx1-Cre;CLEG2 mice conditionally
overexpressing GLI2ΔN in the pancreas develop poorly differentiated
cancers in the absence of concomitant mPanIN lesions. Notably, the
use of a constitutively active mGli2 allele bypasses Hh ligand depen-
dence, which is most relevant to the cognate pathophysiology in the
human pancreas. Similarly, a study by Thayer et al. [43] reported on
mice expressing a constitutively active form of Smoothened (R26-
SmoM2) under the control of a ubiquitously expressed inducible
Cre transgene (CAGGS-CreER). Interestingly, on tamoxifen induc-
tion, a high rate of novel cystic metaplastic lesions was observed in
the pancreata of CAGGS-CreER;R26-SmoM2 mice, largely replacing
the normal pancreatic architecture and showing histomorphologic fea-
tures reminiscent of mucinous cystic neoplasms.
To the best of our knowledge, ours is the first study that examines
ligand-dependent Hh signaling in the adult murine exocrine pancreas,
with or without additional coexpression of an mSmo allele. We demon-
strate that expression of Shh ligand in the adult exocrine pancreas is, by
itself, not sufficient to cause the formation of either noninvasive intra-
ductal mPanIN lesions or invasive adenocarcinomas. On the contrary,
and not unexpectedly, our cohorts of mice demonstrate a marked ex-
pansion of a periacinar stromal cell compartment, reiterating that, in
the absence of concomitant oncogene expression (e.g., Kras) or exocrine
injury (i.e., pancreatitis), stromal cells remain the major Hh ligand re-
cipients in the adult pancreas. Using Ptch-lacZ reporter mice, we observe
X-Gal staining that is restricted to the expanded periacinar stromal cells,
confirming their ability to respond to exogenous Hh signals.
Multiple lines of evidence have now demonstrated that the presence
of primary cilia are a prerequisite for Hh signal transduction [44,45].
On binding of Hh ligand to the membrane receptor Ptch, the inhibi-
tion on Smo is released and Smo is recruited to the cilium [28,46].
Furthermore, SuFu represents a major negative regulator of Hh signal
transduction in vertebrate cells [47–50], and ligand-driven activation
of the Hh pathway might lead to subcellular translocation of a protein
complex containing SuFu and Gli to the tip of primary cilia, where the
inhibitory function of SuFu on Gli is released, so that the latter can
shuttle to the nucleus and induce transcription of Hh target genes, thus
exemplifying the pivotal role of primary cilia in this process [51]. Nota-
bly, we find expression of acetylated tubulin, a primary cilia marker,
in islet cells, the ductal epithelium, and in the expanded periacinar
stromal cells of the adult pancreas but none within acinar cells. The
absence of primary cilia likely explains the inability of mature acinar cells
to respond to secreted Hh ligand in a cell autonomous manner, even
in the setting of enforced coexpression of the Smo receptor. A prior
report by Seeley et al. [52] confirms that murine ductal epithelium
and islets do harbor expression of ciliary markers, consistent with our
own data. The lack of demonstrable pathology within islets or the ductal
epithelium is somewhat surprising, given their apparent competence
to respond to Hh signals and suggests that these compartments have
other checkpoints in place, especially in the absence of additional onco-
genic “driver” influences.
In conclusion, in this study, we describe a genetically engineered
mouse model of Hh pathway activation through Shh ligand over-
expression in acinar cells of the adult pancreas. Shh overexpression
led to a striking expansion of a periacinar stromal cell compartment
but did not induce formation of premalignant precursor lesions or overt
pancreatic neoplasia, in line with stromal cells being the major Hh-
responsive elements in the mature organ. This autochthonous model
serves as a platform for studying epithelial stromal interactions in pan-
creatic carcinogenesis, as well as the role of cooperating genetic altera-
tions with aberrant Hh signaling.
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Figure W1. Developmental overexpression of Shh ligand leads to pancreatic malformation. In Pdx1-Cre;LSL-mShhmice, uniform perinatal
lethality was observed. Necropsy confirmed the presence of a malformed pancreas with marked mesenchymal expansion and mucinous
metaplasia of remnant ducts. Hematoxylin and eosin stains; A and B are ×10 and ×20 images from a single pancreas.
